Overview

MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether MC-1 alone and in combination with an ACE inhibitor is effective in reducing blood pressure and metabolic dysfunctions associated with diabetes
Phase:
Phase 2
Details
Lead Sponsor:
Medicure
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Pyridoxal
Pyridoxal Phosphate